All News

Houra Merrikh and Juan Carvajal-Garcia, PhD, are studying how to prevent cancer therapy resistance. (photo by Erin O. Smith)
September 1, 2023

Foundation funds research to block drug resistance in cancer treatment

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.

By Tom Wilemon
August 31, 2023

New reference tool supports replication of DNA biobank studies

Vanderbilt researchers created a phenotype-genotype reference map to assess data quality in DNA biobanks.

By Paul Govern
August 29, 2023

For VUMC materials management supervisor Kelvin Devane, surgical patients’ needs are top of mind

“I don’t know these people on the table having surgery, but it’s somebody’s dad, somebody’s mom, somebody’s child. I just want to help take care of them.”

By Nancy Humphrey
August 25, 2023

Employing her background in counseling, Shannon Ontiveros brings compassion, advocacy and confidence to the Office of Faculty Affairs

By Bill Snyder
August 24, 2023

Predicting postop opioid use

VUMC study finds that preoperative patient characteristics can predict daily opioid use at six months after surgery, suggesting opportunities for development of electronic risk-stratification algorithms.

By Paul Govern
The team studying how to control sepsis in the lungs and kidneys includes, from left, Huan Qiao, MD, PhD Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, and Yan Liu, MD, MS. (photo by Erin O. Smith)
August 21, 2023

Study reveals genomic code for sepsis in the lungs and kidneys

Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys.

By Bill Snyder
August 10, 2023

New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.
By Tom Wilemon
August 8, 2023

Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.
By Tom Wilemon
August 8, 2023

Renovated pediatric operating rooms enhance state-of-the-art surgical care

Augmented lighting on easy-to-move booms, enhanced imaging that automatically loads into patients’ medical records, and cameras with live feeds to a control room are just a few examples of the newly renovated operating rooms at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
By Christina Echegaray
August 3, 2023

Osterman, Wanderer named associate chief medical information officers

Travis Osterman, DO, MS, and Jonathan Wanderer, MD, MPhil, have been named associate chief medical information officers in HealthIT at Vanderbilt University Medical Center.
By Jenelle Grewell
August 3, 2023

Study finds hallmarks of T cell exhaustion within hours of tumor exposure

Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.
By Leigh MacMillan
August 2, 2023

Personalizing treatment for sinus syndrome

Understanding the inflammatory characteristics of subtypes of chronic rhinosinusitis with polyps should assist with selection of effective therapies, Vanderbilt researchers report.
By Leigh MacMillan
August 2, 2023

VUMC receives $28 million to lead national study of COVID-diabetes link

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.
By Bill Snyder
1 … 57 58 59 60 61 … 104